World AIDS Day: How Genetics Influence HIV Medication Response (Clear PGx Guide for Malaysians)

pro Genome
World AIDS Day: How Genetics Influence HIV Medication Response (Clear PGx Guide for Malaysians)

Introduction

Every year on 1 December, the world comes together to raise awareness about HIV, treatment advancements, and the importance of early care. Today, HIV treatment is safer, stronger, and more effective than ever — people living with HIV can lead long, healthy lives.

But one fact is less commonly known:

Not everyone responds to HIV medications the same way.
Genetics — specifically pharmacogenomics (PGx) — can influence how your body processes certain antiretrovirals (ARVs), how effectively they work, and the likelihood of side effects.

Understanding these variations promotes safer, more personalised HIV care.


1. HIV Treatment Today Is Highly Individualised

ARVs like:

  • Efavirenz
  • Nevirapine
  • Abacavir
  • Atazanavir
  • Dolutegravir
  • Tenofovir
  • Ritonavir

are extremely effective.
But medication success varies between individuals.

Common experiences include:

  • Feeling dizzy or foggy after starting an ARV
  • Difficulty sleeping
  • Unexpected side effects
  • Very fast or very slow response
  • Medication intolerance
  • Switching regimens multiple times

Many of these differences are linked to genetic variations in how the liver and immune system handle medications.


2. Key Genes That Influence HIV Medication Response

Here are three important genes:


✔ CYP2B6 — Efavirenz & Nevirapine Metabolism

Some people metabolise efavirenz slowly → higher drug levels → more side effects:

  • Dizziness
  • Anxiety
  • Vivid dreams
  • Insomnia
  • Cognitive fog

Others metabolise it too fast → drug becomes less effective.

CYP2B6 PGx insights help clinicians:

  • Adjust the dose
  • Choose a better alternative
  • Reduce side effects
  • Improve adherence

✔ HLA-B*5701 — Abacavir Safety

This is one of the best-known PGx markers worldwide.

People with HLA-B*5701 may develop a severe hypersensitivity reaction to Abacavir.

Testing helps prevent this life-threatening condition.
If positive → clinicians avoid Abacavir entirely.


✔ UGT1A1 — Atazanavir & Bilirubin Levels

Some individuals have UGT1A1 variation → higher risk of:

  • Jaundice
  • Yellowing of eyes
  • Slow drug clearance

This isn’t dangerous but can affect treatment comfort and confidence.


3. Why PGx Matters for People Living With HIV

✔ Because HIV treatment is long-term

Medication must be tolerated daily for decades.

✔ Because side effects affect adherence

Even mild dizziness or insomnia can reduce long-term compliance.

✔ Because wrong drug, wrong dose → viral breakthrough

Genetics helps ensure the dose is optimal.

✔ Because personalised care improves quality of life

Less trial-and-error, more precision.


4. NGx (Nutrigenomics) Also Matters in HIV Care

Long-term HIV treatment may influence:

  • Bone health
  • Metabolism
  • Inflammation
  • Vitamin D levels
  • Fat distribution

NGx helps identify:

  • Low Vitamin D activation
  • Omega-3 needs (EPA for inflammation)
  • Magnesium absorption affecting sleep/mood
  • Inflammation sensitivity patterns

Nutrition plays a huge role in supporting immunity and overall recovery.


5. Real Malaysian Case Example (Anonymised)

A 36-year-old man experienced:

  • Severe dizziness
  • Vivid dreams
  • Anxiety
  • Difficulty tolerating his ARV regimen

His PGx results:

  • CYP2B6: Slow metaboliser for efavirenz
    → Drug levels too high → side effects

His doctor switched him to a more suitable ARV.
Within 1–2 weeks:

  • Side effects disappeared
  • Sleep improved
  • Medication adherence restored

This is personalised HIV care in action.


6. What Genetics Cannot Do

To avoid misunderstanding:

❌ It does NOT diagnose HIV
❌ It does NOT predict who will get HIV
❌ It does NOT replace medical consultation
❌ It does NOT replace viral load monitoring

Genetics supports safer, more effective treatment — nothing more, nothing less.


7. Key Takeaway for World AIDS Day

HIV treatment is stronger than ever.
And now, with PGx, it is also becoming smarter.

Personalised medication response leads to:

  • Fewer side effects
  • Better treatment tolerance
  • Higher adherence
  • Improved long-term outcomes

The future of HIV care is precision medicine, and PGx is one of its most important tools.


Conclusion

On this World AIDS Day, we celebrate progress — medically, socially, and scientifically.
And we also recognise that every person living with HIV deserves medication that suits their biology, not guesswork.

The right drug.
At the right dose.
For the right patient.

Back to blog